Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Ellis

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Circulation|December 1, 1994
Increased coronary perforation in the new device era. Incidence, classification, management, and outcomeS G Ellis, S Ajluni, A Z Arnold, et al.
American Heart Journal|April 26, 2001
Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: importance of vessel size in predicting long-term freedom from target vessel revascularizationK M Ziada, S R Kapadia, G Belli, et al.
Circulation|December 22, 1999
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudyS P Marso, A M Lincoff, S G Ellis, et al.
Journal of the American College of Cardiology|September 1, 1995
Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study GroupS C Wong, D S Baim, R A Schatz, et al.
Coronary Artery Disease|November 1, 1993
An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study GroupE M Ohman, E J Topol, R M Califf, et al.
The American Journal of Cardiology|May 10, 2002
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary SyndromesW B Batchelor, C B Granger, N S Kleiman, et al.
Journal of the American College of Cardiology|September 14, 1999
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data setM Moscucci, G T O'Connor, S G Ellis, et al.
Journal of the American College of Cardiology|February 1, 1997
The American College of Cardiology National Database: progress and challenges. American College of Cardiology Database CommitteeW S Weintraub, C R McKay, R N Riner, et al.
Circulation|October 1, 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyJ E Tcheng, S G Ellis, B S George, et al.
Circulation|July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Circulation|December 1, 1994
Increased coronary perforation in the new device era. Incidence, classification, management, and outcomeS G Ellis, S Ajluni, A Z Arnold, et al.
American Heart Journal|April 26, 2001
Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: importance of vessel size in predicting long-term freedom from target vessel revascularizationK M Ziada, S R Kapadia, G Belli, et al.
Circulation|December 22, 1999
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudyS P Marso, A M Lincoff, S G Ellis, et al.
Journal of the American College of Cardiology|September 1, 1995
Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study GroupS C Wong, D S Baim, R A Schatz, et al.
Coronary Artery Disease|November 1, 1993
An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study GroupE M Ohman, E J Topol, R M Califf, et al.
The American Journal of Cardiology|May 10, 2002
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary SyndromesW B Batchelor, C B Granger, N S Kleiman, et al.
Journal of the American College of Cardiology|September 14, 1999
Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data setM Moscucci, G T O'Connor, S G Ellis, et al.
Journal of the American College of Cardiology|February 1, 1997
The American College of Cardiology National Database: progress and challenges. American College of Cardiology Database CommitteeW S Weintraub, C R McKay, R N Riner, et al.
Circulation|October 1, 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyJ E Tcheng, S G Ellis, B S George, et al.
Circulation|July 1, 1997
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.
Pageof 23